Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 0.962 | 1783 | 0 | 2003 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 0.921 | 675 | 0 | 1994 | 2020 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.986 | 654 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.989 | 531 | 0 | 2001 | 2020 | ||||||||
|
promyelocytic leukemia | 0.477 | 0.846 | 0.21 |
|
disease | 0.600 | None | 0.978 | 509 | 0 | 1990 | 2020 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.956 | 502 | 0 | 1976 | 2020 | ||||||||
|
cytochrome c oxidase subunit 8A | 0.400 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.970 | 492 | 0 | 1975 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.967 | 483 | 0 | 1997 | 2020 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.700 | None | 0.981 | 481 | 0 | 1990 | 2020 | ||||||||
|
stathmin 1 | 0.458 | 0.885 | 7.5E-02 |
|
disease | 0.100 | None | 0.985 | 464 | 0 | 1995 | 2020 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
group | 0.100 | None | 0.951 | 449 | 0 | 1984 | 2020 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.100 | None | 0.996 | 445 | 0 | 1998 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.991 | 425 | 0 | 1993 | 2020 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.100 | None | 0.993 | 419 | 0 | 2005 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.100 | None | 0.980 | 404 | 0 | 1989 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.600 | None | 0.969 | 388 | 0 | 1985 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.997 | 385 | 0 | 1987 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.990 | 384 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.990 | 382 | 0 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.989 | 380 | 0 | 2001 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.981 | 372 | 0 | 1995 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.992 | 365 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.992 | 361 | 0 | 2001 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.994 | 355 | 0 | 1992 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.100 | None | 0.977 | 352 | 0 | 1992 | 2020 |